STOCK TITAN

Braveheart Bio: Travis Murdoch reports 9.3% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G

Rhea-AI Filing Summary

Braveheart Bio, Inc. (BRVE) ownership disclosure lists Travis Murdoch, M.D., the reporting person, as beneficially owning 8,379,470 shares of common stock, or 9.3%, as of September 30, 2026. Braveheart Bio had 89,867,737 common shares outstanding on that date. The disclosure states that Murdoch had sole voting and sole dispositive power over 8,379,470 shares; the reported amount includes shares held directly and through trusts, plus options exercisable within 60 days.

Beneficially owned shares 8,379,470 shares Travis Murdoch's reported beneficial ownership as of September 30, 2026
Percent of class 9.3% Travis Murdoch's beneficial ownership as of September 30, 2026
Common shares outstanding 89,867,737 shares As of September 30, 2026
Shares held of record by Travis Murdoch 2,940,670 shares Included in the beneficial ownership reported as of September 30, 2026
Shares held by the Murdoch Family Trust 3,338,175 shares Included in the beneficial ownership reported as of September 30, 2026
Shares held by the Irrevocable Gift Trust for Alizee 1,027,396 shares Included in the beneficial ownership reported as of September 30, 2026
Shares held by the Irrevocable Gift Trust for Siena 1,027,396 shares Included in the beneficial ownership reported as of September 30, 2026
Shares underlying stock options 45,833 shares Options exercisable within 60 days of September 30, 2026
beneficial ownership regulatory
"beneficial ownership of Common Stock"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Sole Voting Power regulatory
"Sole Voting Power 8,379,470.00"
Sole voting power is the exclusive right to cast votes attached to a shareholder’s stock without needing approval from anyone else. Like holding the only remote control for a TV, it lets that holder decide corporate matters such as board members, mergers, and policy changes, making it important to investors because it concentrates control and can strongly influence a company’s strategy and the value of its shares.
Sole Dispositive Power regulatory
"Sole Dispositive Power 8,379,470.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Rule 13d-3(d)(1)(i) regulatory
"in accordance with Rule 13d-3(d)(1)(i)"
shares underlying stock options financial
"45,833 shares of Common Stock underlying stock options"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How is Travis Murdoch's BRVE beneficial ownership made up?

The reported 8,379,470 shares comprise 2,940,670 shares held of record by Travis Murdoch, 3,338,175 held by the Murdoch Family Trust, 1,027,396 held by the Irrevocable Gift Trust for Alizee, 1,027,396 held by the Irrevocable Gift Trust for Siena, and 45,833 shares underlying options exercisable within 60 days of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





10567X101

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G





SCHEDULE 13G



Travis Murdoch
Signature:/s/ Travis Murdoch, M.D.
Name/Title:Travis Murdoch, M.D.
Date:11/16/2026

Keep reading